These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7543641)

  • 1. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.
    Jones R; Franklin K; Spicer R; Berry J
    Lancet; 1995 Aug; 346(8973):499. PubMed ID: 7543641
    [No Abstract]   [Full Text] [Related]  

  • 2. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.
    van Velzen D
    Lancet; 1995 Aug; 346(8973):499-500. PubMed ID: 7543642
    [No Abstract]   [Full Text] [Related]  

  • 3. High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis.
    Oades PJ; Bush A; Ong PS; Brereton RJ
    Lancet; 1994 Jan; 343(8889):109. PubMed ID: 7505872
    [No Abstract]   [Full Text] [Related]  

  • 4. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplementation.
    Doull I; Langton-Hewer S
    Lancet; 1996 Feb; 347(8997):327. PubMed ID: 8569382
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison between cisapride and Gaviscon with Carobel in the treatment of gastro-oesophageal reflux in infancy.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Ir Med J; 1992; 85(4 Suppl):14. PubMed ID: 1490841
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing childhood gastro-oesophageal reflux.
    Drug Ther Bull; 1997 Oct; 35(10):77-80. PubMed ID: 9489057
    [No Abstract]   [Full Text] [Related]  

  • 7. Gaviscon for gastro-oesophageal reflux in infants: a poorly effective treatment?
    Cresi F; Savino F; Marinaccio C; Silvestro L
    Arch Dis Child; 2006 Jan; 91(1):93. PubMed ID: 16371388
    [No Abstract]   [Full Text] [Related]  

  • 8. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.
    Smyth RL; van Velzen D; Smyth AR; Lloyd DA; Heaf DP
    Lancet; 1994 Jan; 343(8889):85-6. PubMed ID: 7903780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements.
    Croft NM; Marshall TG; Ferguson A
    Lancet; 1995 Nov; 346(8985):1265-7. PubMed ID: 7475719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
    Corvaglia L; Aceti A; Mariani E; De Giorgi M; Capretti MG; Faldella G
    Aliment Pharmacol Ther; 2011 Feb; 33(4):466-70. PubMed ID: 21158879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
    Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
    Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
    Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
    Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
    [No Abstract]   [Full Text] [Related]  

  • 13. Progressive pan-colonic fibrosis secondary to oral administration of pancreatic enzymes.
    Moss RL; Musemeche CA; Feddersen RM
    Pediatr Surg Int; 1998 Mar; 13(2-3):168-70. PubMed ID: 9563037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2008; (6):77-81. PubMed ID: 19334430
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of reflux oesophagitis.
    Wesdorp IC
    Scand J Gastroenterol Suppl; 1982; 79():106-19. PubMed ID: 6131532
    [No Abstract]   [Full Text] [Related]  

  • 16. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Arch Dis Child; 1992 May; 67(5):618-21. PubMed ID: 1599300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: revisiting the past--does it hold the key to the future treatment of refractory GERD?
    Katz PO; Schnoll-Sussman F
    Aliment Pharmacol Ther; 2013 Jul; 38(2):202-3. PubMed ID: 23772900
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment with sodium alginate of gastroesophageal reflux disease in childhood: efficacy and tolerance assessment].
    Maestri L
    Pediatr Med Chir; 2001; 23(3-4):187-9. PubMed ID: 11723856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: revisiting the past--does it hold the key to the future treatment of refractory GERD? Author's reply.
    Fox M
    Aliment Pharmacol Ther; 2013 Jul; 38(2):203-4. PubMed ID: 23772901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Can acid pocket-targeting alginate-antacid (Gaviscon Double Action) relieve upper gastrointestinal symptoms in gastro-oesophageal reflux disease?].
    Kim SE; Park MI
    Korean J Gastroenterol; 2014 Jun; 63(6):386-8. PubMed ID: 25097964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.